Abstract:e24276 Background: Hepatocellular carcinoma (HCC), the most common hepatic malignancy, is the second leading cause of cancer-related death worldwide. China accounts for more than 50% of new HCC cases and deaths in the world. The genomic profiles of HCC in Chinese patients had not been thoroughly elucidated to facilitate diagnosis and treatment. Methods: FFPE tumor and matched blood samples of 181 Chinese HCC patients, including 152 males (median age of 54) and 29 females (median age of 52), were collected for next-generation sequencing-based 450 genes panel assay. Genomic alterations (including single base substitutions, short and long insertions/deletions, copy number variations, and gene rearrangement in selected genes) and tumor mutational burden were assessed. In addition, the expression of tumor cell PDL1 was also evaluated by FDA-cleared DAKO 22c3 antibody. Results: The most frequently mutated genes in 181 Chinese HCC were TP53 (59.7%), TERT (34.3%), CTNNB1 (21.5%), AXIN1 (12.2%), RB1 (11.0%), STK24 (11.0%), ARID1A (9.9%), CCND1 (7.7%), TSC2 (6.6%) and FGF19 (6.6%). The mutation rates of TERT (p = 0.027) and RB1 (p = 0.016) were significantly higher in patients (pts) with TMB greater than the cohort medium of 7.2 muts/Mb. In addition, loss of function mutation of PBRM1 was found in 2.8% of the pts. About 7% of the patients had TMB value higher than 20 muts/Mb, compared to 1-2% in Western HCC pts, and 31% higher than 10 muts/Mb. Seventy-four patients (median age 54 years; median TMB 6.8 muts/Mb) had tumorous PDL1 expressions assessed by IHC assay. Thirty-six percent of patients were positive of PDL1 (tumor portion score TPS greater than 1%). Only three pts possessed both high TMB and high PDL1 expression (TPS > 50). No correlation was observed between the expression of PDL1 and TMB (r = 0.1). Conclusions: This is the first genomic profiling study of Chinese HCC pts along with TMB and PDL1 expression results. With less actionable gene alterations but more often high TMB and PDL1 expression than their Western counterparts, Chinese HCC pts could potentially benefit more from immune check point inhibitor-based therapies. However, no correlation was observed between the expressions of PDL1 and TMB values.

Combined pre-S deletion and core promoter mutations related to hepatocellular carcinoma: A nested case-control study in China.

Pre-S Deletion And Complex Mutations Of Hepatitis B Virus Related To Young Age Hepatocellular Carcinoma In Qidong, China

Effect of combined mutations in the enhancer II and basal core promoter of hepatitis B virus on development of hepatocellular carcinoma in Qidong, China.

Association Of Hepatitis B Virus Pre-S Deletions With The Development Of Hepatocellular Carcinoma In Qidong, China

Characterization of Genomic Alterations, Tumor Mutational Burden and PDL1 Expression in 181 Chinese Hepatocellular Carcinomas.

Potential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China

Sequential Accumulation of the Mutations in Core Promoter of Hepatitis B Virus is Associated with the Development of Hepatocellular Carcinoma in Qidong, China.

High Prevalence of Hepatitis B Virus Pre-S Mutation and Its Association with Hepatocellular Carcinoma in Qidong, China.

Temporal Acquisition of Sequential Mutations in the Enhancer Ii and Basal Core Promoter of Hbv in Individuals at High Risk for Hepatocellular Carcinoma

A Case-Control Study of the Relationship Between Hepatitis B Virus DNA Level and Risk of Hepatocellular Carcinoma in Qidong, China

Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.

Prospective Evaluation of Hepatitis B 1762T/1764A Mutations on Hepatocellular Carcinoma Development in Shanghai, China

The Mutation of Hepatitis B Virus and the Prognosis of Hepatocellular Carcinoma after Surgery: a Pilot Study

Associations Between Hepatitis B Virus Mutations and the Risk of Hepatocellular Carcinoma: a Meta-Analysis.

Association between HBV Pre-S mutations and the intracellular HBV DNAs in HBsAg-positive hepatocellular carcinoma in China

Comparison Study on the Complete Sequence of Hepatitis B Virus Identifies New Mutations in Core Gene Associated with Hepatocellular Carcinoma

[The association of hepatitis B virus genotype and the basal core promoter mutation in Qidong, China].

Study on the Complete Sequence of Hepatitis B s Identifies New Mutations in Core Gene Associated with B & P atocellular Carcinoma

Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma

Significant Association of Different Pres Mutations with Hepatitis B-related Cirrhosis or Hepatocellular Carcinoma

Association of Novel Mutations and Heplotypes in the Pres Region of Hepatitis B Virus with Hepatocellular Carcinoma